期刊文献+

肥胖型多囊卵巢综合征患者63例的临床特征 被引量:3

The clinical features of 63 cases with obese polycystic ovary syndrome
下载PDF
导出
摘要 目的:观察和探讨肥胖型多囊卵巢综合征患者的临床特点.方法:回顾性分析我院2012-12/2014-12收治的100例多囊卵巢综合征患者的临床资料,根据患者的身体特征将其中肥胖患者纳入研究组(63例),非肥胖患者纳入对照组(37例).分别对两组患者进行糖脂代谢、内分泌激素检测及常规检查和超声测量,比较两组患者的各项指标水平.结果:研究组患者的IR发生率明显高于对照组,差异有统计学意义(P<0.05).研究组患者的体重、BMI、腰围、臀围和WHR均明显高于对照组,差异均有统计学意义(P<0.05).研究组患者的LL/FSH、LH等指标明显低于对照组,差异均有统计学意义(P<0.05).结论:肥胖型多囊卵巢综合征患者的代谢症候群和内分泌异常的发生率明显高于非肥胖型多囊卵巢综合征患者,因此肥胖型患者需要注意控制自身体重,以减少远期并发症. AIM: To observe the clinical characteristics of obesity type patients with polycystic ovary syndrome . METHODS: Analyze clinical data of 100 cases of patients with polycystic ovary syndrome retrospectively in our hospital from 2012 December to 2014 December, who were divided into study group with obese patients (63 cases) and control group with non-obese patients (37 cases) according to the physical characteristics of the patients. All patients got glucose and lipid metabolism examination, endocrine hormone detection, routine examination and ultrasonic measurement, all indexes were compared between the two groups. RESULTS: The incidence of IR in study group of patients was significantly higher than that in control group (P 〈 0.05), with statistically significant. The weight, BMI, waistline, hipline and WHR in study group were was significantly higher than that in control group (P 〈 0.05), the differences were statistically significant. And the LH/FSH and LH indexes in study group were was significantly higher than that in control group (P 〈 0.05), the differences were statistical significance. CONCLUSION: The incidence of metabolic syndrome and endocrine abnormalities in obese patients with polycystic ovary syndrome are higher than that in non-obese patients. So the obese patients need to pay attention to control their weight in order to reduce long-term complications.
作者 任民
出处 《转化医学电子杂志》 2015年第4期65-66,共2页 E-Journal of Translational Medicine
关键词 肥胖型 多囊卵巢综合征 临床特征 胰岛素抵抗 obesity polycystic ovary syndrome clinical characteristics insulin resistance
  • 相关文献

参考文献4

二级参考文献38

共引文献88

同被引文献39

  • 1陈慧,詹维伟,陈晨,杨志芳,刘振华,毛建平.不同分型多囊卵巢综合征患者的超声特征及其与内分泌指标的相关性[J].中华医学超声杂志(电子版),2013,10(9):763-768. 被引量:40
  • 2顾丽君,刘建华,屠爽,刘膠.超声检查诊断多囊卵巢综合征价值的探讨[J].实用妇产科杂志,2004,20(6):351-352. 被引量:5
  • 3王松.达英-35联合二甲双胍治疗多囊卵巢综合症内分泌代谢紊乱分析[J].中国保健营养(上旬刊),2014,24(3):523-524.
  • 4Baracat MC,Serafini PC,Sim?es Rdos S,et al.Systematic review of cell adhesion molecules and estrogen receptor expression in the endometrium of patients with polycystic ovary syndrome[J].Int J Gynaecol Obstet,2015,129(1):1-4.
  • 5Chua AK,Azziz R,Goodarzi MO.Association study of CYP17 and HSD11B1 in polyeystic ovary syndrome utilizing comprehensive gene coverage[J].Mol Hum Reprod,2012,18(6):320-324.
  • 6Lecke SB,Morsch DM,Spritzer PM.CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome[J].Steroids,2011,76(12):1383-1388.
  • 7Gu BH,Park JM,Back KH.Genetic variations of follicle stimulating hormone receptor are associated with polyeystic ovary syndrome[J].Int J Mol Med,2010,26(1):107-112.
  • 8Kim JW,Lee MH,Park JE,et al.Association of IL-18 genotype with impaired glucose regulation in Korean women with polyeystic ovary syndrome[J].Eur J Obstet Gynecol Reprod Biol,2012,161(1):51-55.
  • 9Li Y,Liu F,Luo S,et al.Polymorphism T→C of gene CYP17promoter and polycystic ovary syndrome risk:a meta analysis[J].Gene,2012,495(1):16-22.
  • 10Dasgupta S,Sirisha P,Neelaveni K,et al.Polymorphisms in the IRS-1 and PPAR-γgenes and their association with polycystic ovary syndrome among South Indian women[J].Gene,2012,503(1):140-146.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部